Roberto Giacomelli researcher
Giacomelli, Roberto, 1950-....
Giacomelli, Roberto
VIAF ID: 4512149235099276690001 (Personal)
Permalink: http://viaf.org/viaf/4512149235099276690001
Preferred Forms
- 200 _ | ‡a Giacomelli ‡b Roberto ‡f 1950-....
- 100 1 _ ‡a Giacomelli, Roberto
-
-
- 100 1 _ ‡a Giacomelli, Roberto ‡d 1950-
- 100 1 _ ‡a Giacomelli, Roberto ‡d 1950-
- 100 1 _ ‡a Giacomelli, Roberto, ‡d 1950-
-
-
- 100 1 _ ‡a Giacomelli, Roberto, ‡d 1950-....
- 100 0 _ ‡a Roberto Giacomelli ‡c researcher
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Achaea Magno-Graeca le iscrizioni arcaiche in alfabeto acheo di Magna Grecia | |
Antídōron scritti minori | |
Essays. Selections | |
Il futuro "italico" in -s(u)- | |
Graeca Italica : studi sul bilinguismo-diglossia nell'Italia antica | |
Grecismi del Messapico | |
Lingua rock : l'italiano dopo il recente costume giovanile | |
Natural killer cell frequency and function in patients with monoclonal gammopathies | |
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients With Sjögren's Syndrome: Comment on the Article by Nocturne et al | |
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma) | |
Non organ based laboratory markers in systemic sclerosis | |
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. | |
La parola e la frase : corso di semantica | |
Pathogenesis of adult onset Still's disease: current understanding and new insights | |
Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis. | |
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset. | |
Phenotypical and Functional Characteristics of In Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells From Patients With Systematic Sclerosis | |
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes | |
Polyclonal B lymphocyte activation in progressive systemic sclerosis | |
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. | |
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis | |
Potential of stem cells in the treatment of rheumatic disease | |
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort | |
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations | |
Problemi di storia linguistica del latino dialettale | |
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers. | |
Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor-Like Molecule 1A+Interleukin-23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune Functions | |
Pupillocynetic activity of substance P in systemic sclerosis | |
Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study. | |
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis | |
[Renal vasculitis: review of the literature and description of a clinical case] | |
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis | |
Response to: 'Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'' by Muraviov and Muraviova | |
Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by | |
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study | |
Ricerche falische | |
Risk factors for Sjögren's syndrome: a case-control study. | |
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome | |
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network | |
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for systemic sclerosis. | |
The role of IL-1β in the bone loss during rheumatic diseases. | |
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. | |
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans | |
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis | |
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare. | |
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor. | |
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. | |
Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis | |
Serologic profile and mortality rates of scleroderma renal crisis in Italy. | |
Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD) | |
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? | |
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm | |
Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy | |
Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis | |
Stem cell therapies for systemic sclerosis. | |
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. | |
strano caso della signora Hélène Smith spiritismo, glossolalia e lingue immaginarie | |
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study | |
Surface Expression of Fractalkine Receptor (CX3CR1) on CD4+/CD28 T Cells in RA Patients and Correlation with Atherosclerotic Damage | |
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients | |
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy | |
T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen | |
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives | |
Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand? | |
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art | |
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis | |
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series. | |
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature | |
Tu sei Pietro e su questa pietra-- | |
Ufanisi na usalama wa matibabu ya rituximab katika ugonjwa wa msingi wa Sjögren: utafiti unaotarajiwa, wa vituo vingi, ufuatiliaji. | |
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma | |
Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: a new era for therapeutic targeting? | |
Variations of neuronal nitric oxide synthase in systemic sclerosis skin | |
Vascular complications of scleroderma | |
The Vessels Contribute to Fibrosis in Systemic Sclerosis | |
Vitamin D and systemic lupus erythematosus - The hype and the hope. | |
Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis | |
What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial. | |
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? | |
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection |